This is the authors' abstract. We don't add key points for this paper.
Patients and families with CHI using CGM noticed trends in glucose levels which motivated behavioural changes to reduce hypoglycaemia with advantages outweighing disadvantages. They expected CHI-specific modifications to enhance utility. Future design of CGM should incorporate end users' opinions and experiences for optimal glycaemic monitoring of CHI.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Auckburally et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: